Healthcare Industry News: Sanofi-aventis
News Release - May 27, 2009
Accumetrics, Inc. Announces European Distribution Channels for France, Austria, Switzerland, Netherlands, Belgium and LuxembourgSAN DIEGO, May 27 -- (Healthcare Sales & Marketing Network) -- Accumetrics, Inc. announces today it has signed new exclusive distribution agreements for its VerifyNow(R) System in several European countries. Distribution of Accumetrics' VerifyNow products will be handled by AAZ in France; BITmedical GmbH in both Austria and Switzerland; and Kordia in the Netherlands, Belgium and Luxembourg. The VerifyNow System assesses response to life-saving antiplatelet therapies, such as aspirin, Plavix(R) and GP IIb/IIIa inhibitors. As response to these drugs varies, the tests help physicians ensure their patients on antiplatelet medications are receiving the optimal benefit.
"We're extremely excited to continue with the global expansion of our distribution strategy for the VerifyNow System. Accumetrics has chosen each of these partners based on their demonstrated expertise and knowledge of our markets in their respective territories," said Timothy I. Still, President and CEO of the Company. "These partnerships demonstrate our ongoing expansion of our distribution channels outside the United States, and support our vision to provide physicians access to critical information for managing their cardiovascular patients on antiplatelet therapies."
About Accumetrics (www.accumetrics.com)
Accumetrics is committed to advancing medical understanding of platelet function and enhancing quality of care for patients receiving antiplatelet therapies by providing industry-leading and widely accessible diagnostic tests for rapid platelet function assessment.
Accumetrics' VerifyNow System is the first rapid and easy to use platform for measuring an individual's response to multiple antiplatelet agents. Addressing every major antiplatelet drug, including EC-cleared product for prasugrel and FDA-cleared products for aspirin, Plavix(R), ReoPro(R), and Integrilin(R), the VerifyNow System provides a valuable tool to help physicians make informed treatment decisions.
The Accumetrics logo and VerifyNow are registered trademarks of Accumetrics, Inc., ReoPro is a registered trademark of Centocor, Inc. Integrilin is a registered trademark of Millennium Pharmaceuticals. Plavix is a registered trademark of Sanofi-aventis.
AAZ-LMB is a French company specializing in In Vitro Diagnostic Products for Diagnostic, Monitoring, Genotyping for anti-coagulation therapy. With a panel of varied products and services, the company focuses on health professionals and patients alike, capitalizing on the emerging interest in anti-coagulation therapy monitoring of patients in decentralized settings and near-patient testing in France.
About BITmedical GmbH
BITmedical GmbH, represents a considerable number of manufacturers and distributes throughout Austria and Switzerland. Using its unique expertise, the company supplies exclusively blood-oriented products and services, mainly in the areas of coagulation and bleeding control.
Kordia is the preferred supplier for innovative product solutions serving customer needs in hemostasis, platelet function testing and cardiology. The company supports laboratory and near-patient solutions with a broad range of products and unparalleled customer service. Kordia supplies more than 500 institutes in Belgium, Luxembourg and the Netherlands with dedicated products and solutions.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.